- Paper Report
- Open Access
Autoreactive marginal B cells in drug-induced lupus
Arthritis Research & Therapy volume 4, Article number: 73050 (2002)
Expansion of autoreactive B cells could explain the presence of autoantibodies in the autoimmune disease, systemic lupus erythematosus (SLE). To gain better insight into the production of autoreactive B cells, the authors have developed a drug-induced model of lupus in BALB/c mice transgenic for the heavy chain of an anti-DNA antibody. Normally, the transgenic mice display effective regulation of the transgene-expressing anti-DNA B cells. When treated with exogenous 17'-estradiol (E2), autoreactive B cells were activated and mice developed a lupus-like disease.
In this model, only a small population of B cells was activated, showing that the autoimmune disease does not result in polyclonal B-cell activation. However, the splenic B-cell development is altered by E2 treatment, with a decrease in transitional B cells and an increase in marginal zone B cells. Moreover, anti-DNA secreting B cells display a marginal zone B cell phenotype. These alterations do not result from CD4+ T-cell activation.
These results demonstrate that an autoreactive marginal zone B-cell population proliferates during SLE development, and may be mechanistically involved in disease induction. The results are very interesting and should permit insights into both the mechanism of B-cell tolerance breakdown and the role played by estrogens in this disease. However, these results were obtained in a nonautoimmune transgenic mouse strain, and the clinical manifestations are not spontaneous but are induced instead by a hormone.
Flow cytometry, immunochemistry, ELISPOT assay
Grimaldi CM, Michael DJ, Diamond B: Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol. 2001, 167: 1886-1890.
About this article
Cite this article
Fournel, S. Autoreactive marginal B cells in drug-induced lupus. Arthritis Res Ther 4, 73050 (2002). https://doi.org/10.1186/ar-2002-73050
- Autoreactive B cells